ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“ESMOImmuno25: Check the programme and register today!
Connect with global experts in cancer treatment and research and explore innovative therapies that are shaping the future of oncology care.
Early registration deadline 8 October 2025.
Learning objectives:
-
Access immersion sessions in immunobiology and immuno-oncology translational research insights;
-
Review state of the art, checkpoint inhibitor-based therapeutic strategies in immuno-oncology;
-
Understand recent developments in immune modulation, including tumour: microenvironment, immunometabolism, epigenetics and cell signalling;
-
Connect with Industry and independent investigators for an overview of research and development in immuno-oncology, including cellular therapies, vaccines and immune modulators, intratumoural immunotherapy and multispecific constructs.”
European Society for Medical Oncology- ESMO announced key themes and learning objectives for ESMO Immuno 2025, with a focus on translational research, immune modulation, checkpoint strategies, and collaborative networking.
Early registration closes on 8 October 2025.
More posts featuring European Society for Medical Oncology.